Institutional & Family Asset Management, LLC Acadia Pharmaceuticals Inc Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020
SELL
$36.42 - $57.0 $1,383 - $2,166
-38 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$39.26 - $52.73 $431 - $580
-11 Reduced 22.45%
38 $2,000
Q1 2020

May 14, 2020
BUY
$31.65 - $46.87 $379 - $562
12 Added 32.43%
49 $2,000
Q3 2019

Nov 14, 2019
SELL
$22.22 - $44.01 $22 - $44
-1 Reduced 2.63%
37 $1,000
Q2 2019

Aug 14, 2019
BUY
$23.32 - $28.12 $886 - $1,068
38 New
38 $1,000

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email